Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia.
Alanazi B, Munje CR, Rastogi N, Williamson AJK, Taylor S, Hole PS, Hodges M, Doyle M, Baker S, Gilkes AF, Knapper S, Pierce A, Whetton AD, Darley RL, Tonks A.
Alanazi B, et al. Among authors: hole ps.
Leukemia. 2020 Feb;34(2):427-440. doi: 10.1038/s41375-019-0596-4. Epub 2019 Oct 14.
Leukemia. 2020.
PMID: 31611628
Free PMC article.